CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Towa Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Towa Pharmaceutical Co Ltd
2-11, Shimbashi-cho
Phone: +81 669009100p:+81 669009100 KADOMA-SHI, OSK  571-8580  Japan Ticker: 45534553
Business Summary
TOWA PHARMACEUTICAL CO., LTD. is engaged in the manufacture and sale of ethical pharmaceutical products. The Company operates through two segments. The Domestic segment manufactures pharmaceutical products and sells them directly to medical institutions through its sales offices, as well as to agents, pharmaceutical wholesalers and other pharmaceutical manufacturers. Through its subsidiaries, the Company engages in businesses such as the research and manufacture of active pharmaceutical ingredients, the production of soft capsules, and the planning, development, and contract manufacturing of health foods and pharmaceuticals. The Overseas segment consists of a holding company that consolidates the generic pharmaceutical business in Europe and the United States. Its group companies have research and development and manufacturing bases in Europe, and are engaged in the generic pharmaceutical sales business and contract research and development and manufacturing business.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20263/31/2026Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chairman of Subsidiary, Representative Director ItsuroYoshida 75 6/1/2024 6/1/1996
Executive Officer, Chief Director of Accounting and Finance ShiroHatagami 4/1/2024 4/1/2024
Senior Managing Director OsamuUchikawa 67 6/24/2026 4/1/2019
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Breckenridge Pharmaceutical, Inc. 200 Connell Drive Berkeley Heights NJ United States

Business Names
Business Name
4553
Breckenridge Pharmaceutical, Inc.
Pensa Investments, S.L.
Protosera, Inc.
Towa Pharmaceutical Co., Ltd.

General Information
Number of Employees: 4,923 (As of 3/31/2026)
Outstanding Shares: 49,227,867 (As of 6/30/2026)
Shareholders: 5,069
Stock Exchange: TYO
Fax Number: +81 669082138


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, October 4, 2026